Related Experiment Video
Updated: May 9, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction
Giuseppe De Luca1, Arnoud W J van 't Hof, Jan Paul Ottervanger
1Department of Cardiology, ISALA Klinieken, Hospital De Weezenlanden, Groot Weezelanden 20, 8011 JW Zwolle, The Netherlands.
European Heart Journal
|February 1, 2005
Summary
Advanced age increases mortality risk in ST-segment elevation myocardial infarction (STEMI) patients undergoing angioplasty. Impaired myocardial perfusion, indicated by blush grade and ST resolution, is a key factor contributing to this higher mortality risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Advanced age is linked to higher mortality in ST-segment elevation myocardial infarction (STEMI) patients.
- The role of impaired myocardial perfusion in this age-related mortality increase remains unclear.
Purpose of the Study:
- To investigate whether impaired myocardial perfusion explains the increased mortality in older STEMI patients treated with primary angioplasty.
Main Methods:
- Analysis of 1548 STEMI patients treated with primary angioplasty.
- Evaluation of myocardial perfusion using myocardial blush grade (MBG) and ST-segment resolution.
- Prospective collection of clinical and follow-up data.
Main Results:
- Older age was associated with a higher risk profile and impaired myocardial perfusion (reduced MBG and ST resolution).
- Both advanced age and poor myocardial perfusion were independent predictors of 1-year mortality.
- A linear relationship was observed between increasing age, decreased perfusion, and higher mortality.
Conclusions:
- Impaired reperfusion is an independent determinant of poor outcomes in elderly STEMI patients.
- This finding highlights the importance of optimizing myocardial perfusion in older STEMI patients undergoing mechanical revascularization.
More Related Videos
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...